AUC of Calvert's formula in targeted intra-arterial carboplatin chemoradiotherapy for cancer of the oral cavity
- PMID: 15150563
- PMCID: PMC2409492
- DOI: 10.1038/sj.bjc.6601818
AUC of Calvert's formula in targeted intra-arterial carboplatin chemoradiotherapy for cancer of the oral cavity
Abstract
We investigated whether intra-arterial administration of carboplatin using Calvert's formula is useful for avoiding thrombocytopenia in targeted chemoradiotherapy in patients with squamous cell cancer of the oral cavity and oropharynx. Carboplatin was infused intra-arterially under digital subtraction angiography in 28 patients. In the first group of patients, the dose of carboplatin was calculated according to the body surface area (BS group). In the second group, the dose was calculated using Calvert's formula (AUC group). The value for AUC (area under concentration vs time curve; mg ml(-1) min(-1)) in the formula was set at 4.5. All patients received concurrent radiotherapy (30 Gy) and were given oral tegafur-uracil (UFT((R)), 400-600 mg day(-1)). The AUC group showed a significantly lower percentage platelet reduction than the BS group (49.0+/-22.0 vs 65.1+/-23.2%; P=0.045) and also tended to have a higher platelet nadir count (10.9+/-4.2 vs 8.4+/-5.8 x 10(4); P=0.27) without reducing the antitumour effect. The value of 4.5 for target AUC is recommended clinically. However, AUC of Calvert's formula could not predict thrombocytopenia associated with intra-arterial chemoradiotherapy due to the variability of the actual AUC.
Figures





Similar articles
-
Blood vessel density correlates with the effects of targeted intra-arterial carboplatin infusion with concurrent radiotherapy for squamous cell carcinomas of the oral cavity and oropharynx.Br J Cancer. 2006 Jun 5;94(11):1580-5. doi: 10.1038/sj.bjc.6603138. Br J Cancer. 2006. PMID: 16670721 Free PMC article.
-
[Evaluation of expected AUC of carboplatin (CBDCA) predicted by Chatelut's formula in comparison with Calvert's].Gan To Kagaku Ryoho. 1997 Mar;24(5):579-83. Gan To Kagaku Ryoho. 1997. PMID: 9087291 Japanese.
-
Evaluation of Calvert's formula for dosage adjustment of carboplatin in Japanese patients with hormone refractory prostate cancer.Biol Pharm Bull. 2006 Jul;29(7):1441-4. doi: 10.1248/bpb.29.1441. Biol Pharm Bull. 2006. PMID: 16819185
-
Clinical pharmacokinetics and dose optimisation of carboplatin.Clin Pharmacokinet. 1997 Sep;33(3):161-83. doi: 10.2165/00003088-199733030-00002. Clin Pharmacokinet. 1997. PMID: 9314610 Review.
-
[Pharmacokinetics and individual dose adjustment of carboplatin].Bull Cancer. 2000 Aug;87 Spec No:17-23. Bull Cancer. 2000. PMID: 11082718 Review. French.
Cited by
-
Blood vessel density correlates with the effects of targeted intra-arterial carboplatin infusion with concurrent radiotherapy for squamous cell carcinomas of the oral cavity and oropharynx.Br J Cancer. 2006 Jun 5;94(11):1580-5. doi: 10.1038/sj.bjc.6603138. Br J Cancer. 2006. PMID: 16670721 Free PMC article.
-
Superselective Intra-arterial Infusion Chemotherapy with Nedaplatin for Oral Cancer: A Pharmacological Study of the Dose Clearance.J Maxillofac Oral Surg. 2015 Sep;14(3):616-23. doi: 10.1007/s12663-014-0730-9. Epub 2014 Dec 6. J Maxillofac Oral Surg. 2015. PMID: 26225053 Free PMC article.
References
-
- Aisner J, Sinibaldi V, Eisenberger M (1992) Carboplatin in the treatment of squamous cell head and neck cancers. Sem Oncol 19: 60–65 - PubMed
-
- Calvert AH, Newell DR, Gumbrell LA, O'Reilly S, Burnell M, Boxall FE, Siddik ZH, Judson IR, Gore ME, Wiltshaw E (1989) Carboplatin dosage: prospective evaluation of a simple formula based on renal function. J Clin Oncol 7: 1748–1756 - PubMed
-
- Carmichael J, Popiela T, Radstone D, Falk S, Borner M, Oza A, Skovsgaard T, Munier S, Martin C (2002) Randomized comparative study of tegafur/uracil and oral leucovorin versus parenteral fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 20: 3617–3627 - PubMed
-
- Hermanek P, Sobin LH (1987) TNM Classification of Malignant Tumours. Berlin: Springer-Verlag 16pp
-
- Imai S, Kajihara Y, Munemori O, Kamei T, Mori T, Handa T, Akisada K, Orita Y (1995) Superselective cisplatin (CDDP)–carboplatin (CBDCA) combined infusion for head and neck cancers. Eur J Radiol 21: 94–99 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous